(RTTNews) - Cyclo Therapeutics, Inc. (CYTH) on Friday announced promising preliminary data from its ongoing Phase 3 TransportNPC study, evaluating Trappsol Cyclo for the treatment of Niemann-Pick ...

Four and a half years ago, Pam and Chris Andrews finally had an answer to the mystery of why their daughter Belle was having trouble walking, was falling down as many as six times a day and was ...

Background: Genetic studies have implicated the NPC1 gene (Niemann Pick type C1) in susceptibility to obesity. Methods: To assess the potential function of NPC1 in obesity, we determined its ...

Chris Hempel has spent the last eight years fighting for the lives of her twin girls. Her 10-year-old daughters, Addi and Cassi, both have Niemann-Pick Type C, an incredibly rare hereditary disease ...

For the first time, National Institutes of Health (NIH) researchers have demonstrated in mice that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick ...

Neiman-Pick type C (NPC) disease intrigues Alzheimer's researchers for several reasons. For one thing, the neurodegenerative disorder involves tau hyperphosphorylation. For another, the two proteins ...

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical-stage biotechnology company dedicated to developing life-changing ...

In the 1990s, the Ara Parseghian Foundation donated money to the National Institutes of Health to sequence the gene associated with a rare disease affecting the three grandchildren of Parseghian, the ...

Obesity is characterized by an excess of white adipose tissue (WAT) and marked adipocyte dysfunction that increase the risk for insulin resistance, type 2 diabetes mellitus and cardiovascular disease.